N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-furo[2,3- c]pyridine- 5-carboxamide hydrochloride PHA 543613 hydrochloride
- CAS No.
- 478149-53-0
- Chemical Name:
- N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-furo[2,3- c]pyridine- 5-carboxamide hydrochloride PHA 543613 hydrochloride
- Synonyms
- PHA-543613;PHA-543613 >=98% (HPLC);PHA 543613 hydrochloride;PHA 543613, 10 mM in DMSO;PHA-543,613 - CAS 478149-53-0 - Calbiochem;(R)-N-(quinuclidin-3-yl)furo[2,3-c]pyridine-5-carboxaMide;N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide;Furo[2,3-c]pyridine-5-carboxamide, N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-;N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]furo[2,3-c]pyridine-5-carboxamide;N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-furo[2,3-c]pyridine-5-carboxamidehydrochloride
- CBNumber:
- CB92503302
- Molecular Formula:
- C15H17N3O2
- Molecular Weight:
- 271.31
- MDL Number:
- MFCD12828748
- MOL File:
- 478149-53-0.mol
- MSDS File:
- SDS
- TDS File:
- TDS
N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-furo[2,3- c]pyridine- 5-carboxamide hydrochloride PHA 543613 hydrochloride Properties
| Melting point | 313-315 °C |
|---|---|
| Boiling point | 508.0±40.0 °C(Predicted) |
| Density | 1.32±0.1 g/cm3(Predicted) |
| storage temp. | Store at +4°C |
| solubility | DMSO: ≥20mg/mL |
| form | White powder |
| pka | 12.19±0.20(Predicted) |
| color | white to off-white |
| InChI | 1S/C15H17N3O2/c19-15(12-7-11-3-6-20-14(11)8-16-12)17-13-9-18-4-1-10(13)2-5-18/h3,6-8,10,13H,1-2,4-5,9H2,(H,17,19)/t13-/m0/s1 |
| InChIKey | IPKZCLGGYKRDES-ZDUSSCGKSA-N |
| SMILES | O=C(N[C@H]1CN2CC[C@H]1CC2)c3cc4ccoc4cn3 |
| FDA UNII | R36R9KVD6Y |
| UNSPSC Code | 51111800 |
| NACRES | NA.77 |
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H319 |
| Precautionary statements | P264-P280-P305+P351+P338-P337+P313P |
| WGK Germany | 1 |
| Storage Class | 11 - Combustible Solids |
N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-furo[2,3- c]pyridine- 5-carboxamide hydrochloride PHA 543613 hydrochloride price More Price(38)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Sigma-Aldrich | PZ0135 | PHA-543613 ≥98% (HPLC) | 478149-53-0 | 5mg | $170 | 2026-04-30 | Buy |
| Sigma-Aldrich | PZ0135 | PHA-543613 ≥98% (HPLC) | 478149-53-0 | 25mg | $637 | 2026-04-30 | Buy |
| Sigma-Aldrich | 5.05316 | PHA-543,613 - CAS 478149-53-0 - Calbiochem | 478149-53-0 | 5MG | $179 | 2022-05-15 | Buy |
| Cayman Chemical | 42222 | PHA-543613 ≥95% | 478149-53-0 | 5mg | $138 | 2026-04-30 | Buy |
| Cayman Chemical | 42222 | PHA-543613 ≥95% | 478149-53-0 | 10mg | $235 | 2026-04-30 | Buy |
N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-furo[2,3- c]pyridine- 5-carboxamide hydrochloride PHA 543613 hydrochloride Chemical Properties,Uses,Production
Uses
PHA-543613 has been used to study its effect on recognition memory and neurovascular coupling (NVC) response in β-amyloid (Aβ) 25-35-treated mice. It has also been used to study its effect on Aβ25-35-induced receptor alteration and cognitive impairment in mice.
Definition
ChEBI: Pha-543613 is a phosphoramide and an organothiophosphorus compound.
Biological Activity
Primary Target
α7 nAChR
in vivo
PHA-543613 (0.3 mg/kg) successfully reverses Scopolamine-induced short-term memory deficits in rats[2]. PHA-543613 (4 and 12 mg/kg; i.p. once) reduces behavioral deficits and brain edema[3].
| Animal Model: | Male CD-1 mice with (intracerebral hemorrhage) ICH-induction or sham surgery[3] |
| Dosage: | 4 and 12 mg/kg |
| Administration: | Intraperitoneal injection; 4 and 12 mg/kg; 1 hour after surgery |
| Result: | Increased p-Akt and decreased p-GSK-3 and CC3 expressions in the ipsilateral hemisphere and reduced the neuronal cell death in the perihematomal area. Attenuated behavioral deficits and brain edema at 72 hours after ICH. |
N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-furo[2,3- c]pyridine- 5-carboxamide hydrochloride PHA 543613 hydrochloride Preparation Products And Raw materials
Raw materials
Preparation Products
N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-furo[2,3- c]pyridine- 5-carboxamide hydrochloride PHA 543613 hydrochloride Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| 3B Pharmachem (Wuhan) International Co.,Ltd. | 18930552037 | 3bsc@sina.com | China | 15813 | 69 |
| Syntechem Co.,Ltd | info@syntechem.com | China | 12973 | 57 | |
| Sinopharm Chemical Reagent Co,Ltd. | 86-21-63210123 | sj_scrc@sinopharm.com | China | 9791 | 79 |
| Shanghai Lollane Biological Technology Co.,Ltd. | 021-52996696,15000506266 15000506266 | China | 4861 | 55 | |
| EMMX Biotechnology LLC | 888-539-0666 | info@emmx.com | United States | 8435 | 60 |
| Shanghai EFE Biological Technology Co., Ltd. | 021-65675885 18964387627 | info@efebio.com | China | 9799 | 58 |
| Shanghai Rechem science Co., Ltd. | 021-31433387 15618786686 | sales@rechemscience.com | China | 2971 | 58 |
| Shanghai Chaolan Chemical Technology Center | QQ:65489617 13301690235 | Sales@ATKchemical.com | China | 9699 | 58 |
| Wellman Pharmaceutical Group Limited | 15807197853 18971451745 | 15807197853@163.com | China | 3968 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
View Lastest Price from N-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-furo[2,3- c]pyridine- 5-carboxamide hydrochloride PHA 543613 hydrochloride manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-10 | PHA 543613
478149-53-0
|
1KG | 98% | 20Tons | Shaanxi Dideu New Materials Co. Ltd | ||
![]() |
2026-05-25 | PHA 543613
478149-53-0
|
$46.00-178.00 | 99.96% | 10g | TargetMol Chemicals Inc. |
-

- PHA 543613
478149-53-0
- 98%
- Shaanxi Dideu New Materials Co. Ltd
-

- PHA 543613
478149-53-0
- $46.00-178.00
- 99.96%
- TargetMol Chemicals Inc.





